Latest News

The Institute of Pharmaceutical Medicine at the University of Basel invited Bryan Bennett from Adelphi Values to give a lecture to students of the post-graduate ‘European Course of Pharmaceutical Medicine’, a course which is typically undertaken by pharmaceutical industry professionals. The lecture titled ‘Epidemiology and patient-reported outcome studies’ was part… Read More

Thanks to all our clients and colleagues who visited our exhibition stand at ISPOR US which took place in Washington DC. As a result of your support, we have donated $500 to JDRF this year’s chosen charity. JDRF is a charitable organisation that supports sufferers and families… Read More

In June, our Boston team volunteered their time at one of the homeless shelters run by Heading Home , a non-profit organisation in Cambridge US. Heading Home provides emergency, transitional and permanent housing, as well as a variety of support services, to low-income homeless and formerly homeless families… Read More

Meet the team presenting and exhibiting at the 21st Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, taking place 23rd–25th May in Washington DC. Building on the success of previous ISPOR conferences, this year we will be hosting two workshops and presenting… Read More

We are honoured to have been invited to present at the 7th Annual Critical Path Institute Patient-Reported Outcome (PRO) Consortium Workshop to be held in Silver Spring, Maryland on 27th-28th April 2016. Rob Arbuckle, Managing Director of our UK Patient-Centered Outcomes practice, will be presenting two case studies as part… Read More

Increasing numbers of rare diseases are being recognised and more medicines to treat them are being developed. There are several unique challenges for developing evidence packages in rare diseases such as the paucity of information on patient populations, disease progression and appropriate Clinical Outcome Assessments (COAs). As with all clinical… Read More

Oncology is an area that is notoriously hard to achieve patient-reported outcome label claims, but experts at Adelphi Values continue to evaluate ways to work with the FDA guidelines to ensure data are robust and stand up to the scrutiny of regulators. To demonstrate this, and in collaboration with Novartis,… Read More

This week we are attending the 6th Annual World Orphan Drug Congress in Geneva, Switzerland. We are pleased to be presenting a poster entitled ‘Development of patient-centred outcomes in rare diseases’ which will focus on the need for the development of new treatments for rare diseases and indications with orphan… Read More

We are exhibiting and presenting at the 18th Annual European Conference of ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, which takes place from 9th-11th November 2015 in Milan, Italy. Representatives from each of our four practices and both the UK and US offices, will be attending the event. Read More

We are delighted to have recently been invited to present during the prestigious eCOA Forum Scientific Sessions which will be taking place at Oxford University, United Kingdom on 27th-29th October 2015.  Hosted by CRF Health, the conference brings together some of the healthcare industry’s leading professionals and will incorporate educational… Read More

On October 5th 2015, Alan Shields, PhD from Adelphi Values USA will be chairing a session entitled ‘Use and Usefulness of PRO Endpoints in Oncology Trials’ to be held from 12pm to 5pm.  This session is part of a broader DIA (Drug Information Association) conference in Bethesda, Maryland, USA entitled… Read More

In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers. Broad-based healthcare reforms, new pricing regulations, increasing tendering processes and emphasis on value-based assessment are all changing the game for pricing and reimbursement, while raising hurdles for market access. Read More

Adelphi Values is pleased to report that on 29 April 2015 the US FDA granted approval of KYBELLA™ indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Developed by Kythera Biopharmaceuticals®,  KYBELLA™ is the FIRST and ONLY approved non-surgical treatment… Read More

There is growing momentum among researchers, regulatory agencies, policy makers and payers towards a more patient-centric approach to health outcomes research and participation of patients in clinical trials. On 25 June 2015 at 3pm (GMT) PMGroup, in association with Adelphi Values, will host a free webinar showing how a more… Read More

In clinical trials, we put a lot of thought into asking patients how they feel about their disease. But often we neglect to ask them what they think about the trial itself. This feedback can be crucial in improving trial design and execution, and ensuring trials are patient-centric. In order… Read More

Adelphi will be at ISPOR US in May, exhibiting at booths 411/413.  Senior representatives from Adelphi Values will be there alongside colleagues from our sister company Adelphi Real World. The theme for the conference this year is titled ‘Integrating Big Data, Patient Data, and Cost-Effectiveness into Clinical Practice: Promise and… Read More

Once again, Adelphi Values has been invited to participate in the C-Path Patient-Reported Outcome Consortium Workshop which will be taking place in Silver Spring, MD on 29-30th April 2015. Alan Shields, SVP, Endpoint Development & Outcomes, will participate in a discussion panel titled ‘Patient Reported Endpoints and the… Read More

In March, staff from across the Adelphi Group came together to support World Down Syndrome Day, and raise some much needed funds for a local charity close to our hearts, the Cheshire Downs Syndrome Support Group (CDSSG). We donned our odd socks, shared pictures on social media and each made… Read More

Once again, Adelphi pulled out all the stops on March 13th to support Red Nose Day in the UK and ran a number of activities to raise money for this great cause.  Teams from the Adelphi Group, Adelphi Communications, Adelphi Real World, Adelphi Research and Adelphi Values donned their red… Read More

It is with great pleasure we write that, once again, Adelphi Values will be exhibiting at ISPOR EU, Amsterdam, 8-12th November. We have a number of exciting things in store, including: A podium presentation titled ‘Elicitation of health state utilities associated with varying severities of flare in systemic lupus erythematosus’… Read More